Intra-Cellular Therapies, Inc. Reports Fourth Quarter And Full-Year 2013 Financial Results
Published: Mar 26, 2014
NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the fourth quarter and year ended December 31, 2013, and provided an update on corporate developments and upcoming events.
Help employers find you! Check out all the jobs and post your resume.